Biotech Mergers: Evaluating Risk, Reporting, and Integration of Growth Strategies : Gilead’s Acquisition of Immunomedics: Risk and a Growth Strategy . The Accounting Educators’ Journal, [S. l.], v. 33, 2025. Disponível em: https://aejournal.com/ojs/index.php/aej/article/view/1044. Acesso em: 12 oct. 2026.